c-fos antisense DNA inhibits proliferation of osteoclast progenitors in osteoclast development but not macrophage differentiation in vitro

Bone

Volumn 18, Issue 6, 1996, Pages 511-516

  Udagawa, N ^a   Chan, J ^b   Wada, S ^b   Findlay, D M ^b   Hamilton, J A ^b   Martin, T J ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE

Author keywords

Bone resorption; c fos protooncogene; CSF 1; Macrophage; Osteoblast; Osteoclast

Indexed keywords

ANTIGEN; ANTIMITOTIC AGENT; COMPLEMENTARY DNA; OLIGONUCLEOTIDE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; MACROPHAGE; MALE; MOUSE; NEWBORN; NONHUMAN; ONCOGENE C FOS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTO ONCOGENE; STEM CELL;

EID: 0030176340     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/8756-3282(96)00076-2     Document Type: Article

References (31)

1. 1. Baum, M. J., Brown, J. J., Kica, E., Rubin, B. S., Johnson, R. S., and Papaioannou, V. E. Effect of a null mutation of the c-fos proto-oncogene on sexual behavior of male mice. Biol Reprod 50:1040-1048; 1994.
2. 2. van Beveren, C., van Straaten, F., Curran, T., Mueller, R., and Verma, I. M. Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals the viral and cellular fos gene products have different carboxy terminals. Cell 32:1241-1255; 1983.
3. 3. Bradley, T. R., Hodgson, G. S., and Bertoncello, I. High proliferative potential colony forming cells. In: Pollard, J. W. and Walker, J. M., Eds. Methods in Molecular Biology. Vol. 5. Clifton, NJ: Humana: 1990; 289-297.
4. btsA58 transgenic mouse. Proc Natl Acad Sci USA. 90:5578-5582; 1993.
5. 5. Chang, M. W., Barr, E., Seltzer, J., Jiang, Y.-Q., Nabel, G. J., Nabel, E.G., Parmacek, M. S., and Leiden, J. M. Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product. Science 267:518-522; 1995.
6. 6. Field, S., Johnson, R. S., Mortenson, R. M., Papioannou, V. E., Spiegelman, B. M., and Greenberg, M. E. Growth and differentiation of embryonic stem cells that lack an intact c-fos gene. Proc Natl Acad Sci USA 89:9306-9310; 1992.
7. 7. Grigoriadis, A. E., Schellander, K., Wang, Z.-Q., and Wagner, E. F. Osteoblasts are target cells for transformation in c-fos transgenic mice. J Cell Biol 122:685-701; 1993.
8. 8. Grigoriadis, A. E., Wang, Z.-Q., Cecchini, M. G., Hofstetter, W., Felix, R., Fleisch, H. A., and Wagner, E. F. c-fos: A key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266:443-448; 1994.
9. 9. Guvakova, M. A., Yakubov, L. A., Vlodavsky, I., Tonkinson, J. L., and Stein, C. A. Phosphorothioate oligodeoxynucleotides binds to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem 270:2620-2627; 1995.
10. 10. Johnson, R. S., Spiegelman, B. M., and Papaioannou, V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 71:577-586; 1992.
11. 11. Kano, J., Sugimoto, T., Kanatani, M., Kuroki, Y., Tsukamoto, T., Fukase, M., and Chihara, K. Second messenger signaling of c-fos gene induction by parathyroid hormone (PTH) and PTH-related peptide in osteoblastic osteosarcoma cells: its role in osteoblast proliferation and osteoclast-like cell formation. J Cell Physiol 161:358-366; 1994.
12. 12. Lan, H. Y., Mu, W., Nikolic-Paterson, D. J., and Atkins, R. C. A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody cross reactivity of retrieve antigens. J Histochem Cytochem 43:97-102; 1995.
13. 13. Machwate, M., Jullienne, A., Moukhtar, M., Lomri, A., and Marie, P. J. c-fos Protooncogene is involved in the mitogenic effect of transforming growth factor-β in osteoblastic cells. Mol Endocrinol 9:187-198; 1995.
14. 14. Metcalf, D. and Nicolla, N. A. The clonal proliferation of normal mouse hematopoietic cells: enhancement and suppression by colony-stimulating factor combinations. Blood 79:2861-2866; 1992.
15. 15. Miyauchi, A., Kuroki, Y., Fukase, M., Fujita, T., Chihara, K., and Shiozawa, S. Persistent expression of proto-oncogene c-fos stimulates osteoclast differentiation. Biochem Biophys Res Commun 205:1547-1555; 1994.
16. 16. Okada, S., Wang, Z.-Q., Grigoriadis, A. E., Wagner, E. F., and Ruden, T. Mice lacking c-fos have normal hematopoietic stem cells but exhibit altered B-cell differentiation due to an impaired bone marrow environment. Mol Cell Biol 14:382-390; 1994.
17. 17. Papadopoulos, V. and Dym, M. Sertoli cell differentiation on basement membrane is mediated by the c-fos protooncogene. Proc Natl Acad Svi USA 91:7027-7031; 1994.
18. 18. Paylor, R., Johnson, R. S., Papaioannou, V., Spiegelman, B. M., and Wehner, J. M. Behavioral assessment of c-fos mutant mice. Brain Res 651:275-282; 1994.
19. 19. Ransone, L. J. and Verma, I. M. Nuclear proto-oncogenes fos and jun. Annu Rev Cell Biol 6:539-557; 1990.
20. 20. Ruther, U., Garber, C., Komitowski, R., Muller, R., and Wagner, E. F. Deregulated c-fos expression interferes with normal bone development in transgenic mice. Nature (London) 325:412-416; 1987.
21. 21. Stein, C. A. and Cheng, Y.-C. Antisense oligonucleotides as therapeutic agents-Is the bullet really magical? Science 261:1004-1012; 1993.
22. 22. Suda, T., Takahashi, N., and Martin, T. J. Modulation of osteoclast differentiation. Endocrine Rev 13:66-88; 1992.
23. 23. Suda, T., Takahashi, N., and Martin, T. J. Modulation of osteoclast differentiation: Update. In: Bikle, D. D. and Negrovilar, A., Eds. Endocrine Rev Monographs. Vol. 4. Bethesda, MD: Endocrine Soc; 1995; 266-270.
24. 24. Takahashi, N., Akatsu, T., Udagawa, N., Sasaki. T., Yamaguchi, A., Moseley, J. M., Martin, T. J., and Suda, T. Osteoblastic cells are involved in osteoclast formation. Endocrinology 123:2600-2602; 1988.
25. 25. Tamura, T., Takahashi, N., Akatsu, T., Sasaki, T., Udagawa, N., Tanaka, S., and Suda, T. New resorption assay with mouse osteoclast-like multinucleated cells formed in vitro. J Bone Miner Res 8:953-960; 1993.
26. 26. Tanaka, S., Takahashi, N., Udagawa, N., Tamura, T., Akatsu, T., Stanley, E. R., Kurokawa, T., and Suda, T. Macrophage-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors, J Clin Invest 91:257-263; 1993.
27. 27. Udagawa, N., Takahashi, N., Akatsu, T., Tanaka, H., Sasaki, T., Nishihara, T., Koga, T., Martin, T. J., and Suda, T. Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260-7264; 1990.
28. 28. Udagawa, N., Takahashi, N., Katagiri, T., Tamura, T, Wada, S., Findlay, D. M., Martin, T. J., Hirota, H., Taga, T., Kishimoto, T., and Suda, T. IL-6 induction of osteoclast differentiation depends upon IL-6 receptors expressed on osteoblastic cells, but not on osteoclast progenitors. J Exp Med 182:1461-1468; 1995.
29. 29. Wagner, R. W. Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335; 1994.
30. 30. Wang, Z.-Q., Ovitt, C., Grigoriadis, A. E., Möhle-Steinlein, U., Rüther, U., and Wagner, E. F. A novel target for c-fos-induced oncogenesis: Development of chondrogenic tumors in embryonic stem cell chimeras. EMBO J 10:2437-2450; 1991.
31. 31. Wang, Z.-Q., Ovitt, C., Grigoriadis, A. E., Möhle-Steinlein. U., Rüther, U., and Wagner, E. F. Bone and haematopoeitic defects in mice lacking c-fos. Nature (London) 360:741-745; 1992.